-
MYOS RENS Technology Inc (NASDAQ: MYOS) shares
jumped 42.5 percent to $5.14. MYOS RENS Technology shares have surged 140.67 percent over the past 52 weeks, while the S&P
500 index has gained 23.69 percent in the same period.
-
Signal Genetics Inc (NASDAQ: SGNL) shares surged
32.7 percent to $14.00.
-
Benitec Biopharma Ltd (ADR) (NASDAQ: BNTC) shares
gained 32.5 percent to $3.30.
-
Real Goods Solar, Inc. (NASDAQ: RGSE) shares
climbed 26.7 percent to $3.10 after dropping 7.89 percent on Monday. RGS Energy disclosed that it has completed its $11.5
million public offering of common stock and warrants.
-
Document Security Systems, Inc. (NYSE: DSS) rose
16.1 percent to $1.44 after the company disclosed that its AuthentiGuard solution has been selected for global
anti-counterfeiting deployment.
-
Perceptron, Inc. (NASDAQ: PRCP) shares surged 14
percent to $7.25. Perceptron reported Q2 earnings of $0.27 per share on revenue of $21.75 million.
-
Anavex Life Sciences Corp. (NASDAQ: AVXL) shares
surged 11 percent to $5.66. Anavex reported a Q1 loss of $0.08 per share. Noble Financial initiated coverage on Anavex Life
Sciences with a Buy rating.
-
Model N Inc (NYSE: MODN) shares gained 5 percent to
$9.65 after the company posted a narrower-than-expected quarterly loss and raised its full-year forecast.
-
Bioverativ Inc (NASDAQ: BIVV) gained 4 percent to
$44.55. Raymond James initiated coverage of Bioverativ with a Strong Buy rating.
-
Stage Stores Inc (NYSE: SSI) rose 3.3 percent to
$2.53. Northcoast Research upgraded Stage Stores from Sell to Neutral.
-
Nokia Corp (ADR) (NYSE: NOK) gained 2.4 percent to
$4.86. Morgan Stanley upgraded Nokia from Equal-Weight to Overweight.
-
Fabrinet (NYSE: FN) shares rose 2.1 percent to $42.98
after the company reported better-than-expected Q2 results.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.